Skip to main content

Table 4 Reports of stereotactic radiotherapy for stage I non-small cell lung cancer

From: Prognostic factors for local control of stage I non-small cell lung cancer in stereotactic radiotherapy: a retrospective analysis

First author (Reference No.) Number of patients Total dose (Gy) Single dose (Gy/fraction) BED10 (Gy) Median follow up (months) Local control (%)** 3-year overall survival (%)
Timmerman[6] 55 60 20 180 34.4 98.2 55.8
Nagata[5]* 42 48 12 105.6 30 97.8 83
Fakiris[7] 70 60, 66 20, 22 180 - 211.2 50.2 94.3 42.7
Onishi[3]* 257 18 - 75 4.4 - 35 57.6 - 180 38 88.7 56.8
Our results* 80 48 - 60 4 – 12 84 – 105.6 30.4 92.5 89.9
  1. BED10 is biological effective dose (BED) calculated from prescribed dose.
  2. * Dose is calculated at the iso-center.
  3. **Local control (%) = (number of patients without local recurrence) / (number of all patients)×100.